NAAG Asks FDA for Progress Update Under the SUPPORT Act
We have witnessed first-hand the devastation that the opioid epidemic has wrought on states in terms of lives lost and the costs it has imposed on our healthcare system and the broader economy.
Attorneys General Push FDA to Examine Progress in Opioid Fight
Washington, D.C. — The National Association of Attorneys General (NAAG) sent a letter asking the U.S. Food and Drug Administration (FDA) to examine recent progress in the agency’s fight against the opioid epidemic. The bipartisan coalition of state and territory attorneys general is seeking a progress report regarding recent steps taken by the FDA to…
Attorneys General Call for Federal Legislation to Return Prescription Drug Settlement Money to the States
We request your assistance in addressing this inequity and recommend federal legislation that would allow the Federal government to return a proportionate share of all Part D recoveries to the states.
Attorneys General Urge Congress to Repeal Ensuring Patient Access and Effective Drug Enforcement Act of 2016
The Act, which was signed into law on April 19, 2016, is a step backward in our collective effort to prevent the diversion and misuse of prescription drugs and address our worsening epidemic of opioid addiction and overdose deaths.
NAAG Endorses Stopping Overdoses of Fentanyl Analogues (SOFA) Act
States and localities are on the front line of this crisis and are a large part of winning the battle from both a law enforcement and public health perspective.
Congress Should Pass the SAFE Banking Act
NAAG sent a letter to congressional leadership, urging them to pass the SAFE Banking Act. The bipartisan SAFE Banking Act would protect financial institutions that provide services to companies in the marijuana industry. Although the use of marijuana, both recreationally and medically, is legal in some states and territories, banks may still be held liable…
NAAG Endorses the FIGHT Act
This legislation is crucial to federal and state efforts to curb the opioid epidemic nationally and within each individual state. It is for these reasons that we commend Senators Portman and Manchin for their leadership in bringing forward this important legislation, and we urge you to take up and pass S. 2701 before the DEA’s temporary order expires.
AGs Urge Health Insurance Companies to Reduce Provider Incentives for Prescribing Pain Killers
The undersigned State Attorneys General are urging America’s Health Insurance Plans (AHIP) to take proactive steps to encourage your members to review their payment and coverage policies and revise them, as necessary and appropriate, to encourage healthcare providers to prioritize non-opioid pain management options over opioid prescriptions for the treatment of chronic, non-cancer pain.
Pass Federal Legislation to Hold Irresponsible Drug Manufacturers Accountable
State attorneys general have been fighting the opioid crisis on numerous fronts, including protecting consumers from deceptive marketing of prescription opioids, disrupting illicit trafficking networks, and closing pill mills.
NAAG Requests Removal of Federal Barriers to Treat Opioid Use Disorder
Unfortunately, there are three significant barriers to treating opioid use disorder that we cannot change at the state level and that must be tackled at the federal level. We share these barriers below in the hope that we can work together to remove them and allow more providers to offer treatment for opioid use disorder and other substance use disorders.
